bioMerieux SA. – Strategy, SWOT and Corporate Finance Report

bioMerieux SA. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

bioMerieux SA (bioMerieux or 'the company'), is a provider of diagnostic solutions for medical and industrial applications. These products are used to diagnose cardiovascular diseases, targeted cancers and infectious diseases and provides various vitro diagnostic solutions for hospitals. It also offers sterility and quality testings for cosmetics, pharmaceutical and food sectors. It has operations across Europe, the Middle East and Africa (EMEA), the Americas and Asia Pacific. The company is headquartered in Marcy l'Etoile, France.

Scope

– Detailed information on bioMerieux SA. required for business and competitor intelligence needs

– A study of the major internal and external factors affecting bioMerieux SA. in the form of a SWOT analysis

– An in-depth view of the business model of bioMerieux SA. including a breakdown and examination of key business segments

– Intelligence on bioMerieux SA.'s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors

– News about bioMerieux SA., such as business expansion, restructuring, and contract wins

– Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of bioMerieux SA. and the factors that influence its strategies.

- Track strategic initiatives of the company and latest corporate news and actions.

- Assess bioMerieux SA. as a prospective partner, vendor or supplier.

- Support sales activities by understanding your customers' businesses better.

- Stay up to date on bioMerieux SA.'s business structure, strategy and prospects.

Table of Contents

Table of Contents

Company Snapshot

Table of Contents

bioMerieux SA.: Company Overview

bioMerieux SA.: Overview and Key Facts

bioMerieux SA.: Overview

bioMerieux SA.: Key Facts

bioMerieux SA.: Key Employees

bioMerieux SA.: Key Employee Biographies

bioMerieux SA.: Major Products and Services

bioMerieux SA.: Company History

bioMerieux SA.: Management Statement

bioMerieux SA.: Locations and Subsidiaries

bioMerieux SA.: Key Competitors

bioMerieux SA.: Company Analysis

bioMerieux SA.: Business Description

bioMerieux SA.: SWOT Analysis

bioMerieux SA.: SWOT Overview

bioMerieux SA.: Strengths

bioMerieux SA.: Weaknesses

bioMerieux SA.: Opportunities

bioMerieux SA.: Threats

bioMerieux SA.: Corporate Financial Deals Activity

bioMerieux SA.: Financial Deals Overview

bioMerieux SA.: Targets and Partners

bioMerieux SA.: Top Deals 2016 - 2020YTD*

bioMerieux SA.: Advisors

bioMerieux SA.: Top Legal Advisors

bioMerieux SA.: Mergers and Acquisitions

bioMerieux SA.: Corporate Venturing

bioMerieux SA.: Partnership

bioMerieux SA.: Recent Developments

bioMerieux SA.: News and Events Summary

bioMerieux SA.: Business Expansion

bioMerieux SA.: Financial Performance

bioMerieux SA.: Market Developments

bioMerieux SA.: Regulatory and Legal Events

bioMerieux SA.: Strategy and Operations

Appendix

Contact Us

Methodology

About MarketLine

List of Tables

List of Tables

Table 1: bioMerieux SA.: Key Facts

Table 2: bioMerieux SA.: Key Employees

Table 3: bioMerieux SA.: Company History

Table 4: bioMerieux SA.: Locations and Subsidiaries

Table 5: bioMerieux SA.: Key Competitors

Table 6: bioMerieux SA.: Deal Activity by Deal Type – Volume (TTM*)

Table 7: bioMerieux SA.: M&A Activity by Geography (TTM*)

Table 8: bioMerieux SA.: Deal Activity by Deal Type – Volume (2016 – YTD*2020)

Table 9: bioMerieux SA.: M&A Average Deal Size – Value (US$m)

Table 10: bioMerieux SA.: Targets and Partners

Table 11: bioMerieux SA.: Top Deals 2016 – 2020YTD*

Table 12: bioMerieux SA.: Legal Advisor Ranking by Value (US$m)

Table 13: bioMerieux SA.: M&A Volume and Value Trend (2016 – YTD*2020)

Table 14: bioMerieux SA.: M&A Activity by Geography (2016 – YTD*2020)

Table 15: bioMerieux SA.: Corporate Venturing Volume and Value Trend (2016 – YTD*2020)

Table 16: bioMerieux SA.: Corporate Venturing by Geography (2016 – YTD*2020)

Table 17: bioMerieux SA.: Partnership Volume and Value Trend (2016 – YTD*2020)

Table 18: bioMerieux SA.: Partnership Trend by Deal Type (2016 – YTD*2020)

Table 19: bioMerieux SA.: News and Events Summary

Table 20: bioMerieux SA.: Business Expansion

Table 21: bioMerieux SA.: Financial Performance

Table 22: bioMerieux SA.: Market Developments

Table 23: bioMerieux SA.: Regulatory and Legal Events

Table 24: bioMerieux SA.: Strategy and Operations

List of Figures

List of Figures

Figure 1: bioMerieux SA.: Deal Activity by Deal Type – Volume (TTM*)

Figure 2: bioMerieux SA.: M&A Activity by Geography (TTM*)

Figure 3: bioMerieux SA.: Deal Activity by Deal Type – Volume (2016 – YTD*2020)

Figure 4: bioMerieux SA.: M&A Average Deal Size – Value (US$m)

Figure 5: bioMerieux SA.: M&A Volume and Value Trend (2016 – YTD*2020)

Figure 6: bioMerieux SA.: M&A Activity by Geography (2016 – YTD*2020)

Figure 7: bioMerieux SA.: Corporate Venturing Volume and Value Trend (2016 – YTD*2020)

Figure 8: bioMerieux SA.: Corporate Venturing by Geography (2016 – YTD*2020)

Figure 9: bioMerieux SA.: Partnership Volume and Value Trend (2016 – YTD*2020)

Figure 10: bioMerieux SA.: Partnership Trend by Deal Type (2016 – YTD*2020)

    Pricing

Discounts available for multiple report purchases.

reportstore@marketline.com
+44 (0) 161 359 5817

Saved reports